We observed over half of patients with RA were seropositive for both RF and ACPA, and that 28.6% were autoantibody-negative in our study population, which is broadly in line with existing epidemiological data which suggests a frequency of 20–30% [15]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.